Reply To: Traders Market Weekly: Naive Markets and The Fed Fortune Tellers

#65646
Truman
Participant

ARS Pharmaceuticals (SPRY 2.73, -3.88, -58.7%): receives Complete Response Letter from FDA for neffy NDA